G0482 — Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performedHCPCS/CPT
No Prior Auth Required
Code is covered without prior authorization (high confidence)
A56915 — Billing and Coding: Urine Drug Testing
J05
L34645 — Urine Drug Testing
J05
A59416 — Billing and Coding: Urine Drug Testing
J06
L39611 — Urine Drug Testing
J06
A57077 — Billing and Coding: Controlled Substance Monitoring and Drugs of Abuse Testing
J09
L36393 — Controlled Substance Monitoring and Drugs of Abuse Testing
J09
L35006 — Controlled Substance Monitoring and Drugs of Abuse Testing
J12
A56645 — Billing and Coding: Controlled Substance Monitoring and Drugs of Abuse Testing
J12
BCBSIL-MED207.154 — Drug Testing in Pain Management and Substance Use Disorder Treatment
BCBSMT-MED207.154 — Drug Testing in Pain Management and Substance Use Disorder Treatment
BCBSNM-MED207.154 — Drug Testing in Pain Management and Substance Use Disorder Treatment
BCBSOK-MED207.154 — Drug Testing in Pain Management and Substance Use Disorder Treatment
REGENCE-LAB68 — Drug Testing for Substance Use and Pain Management
REGENCE-LAB68a — Drug Testing for Substance Use and Pain Management
AMBETTER-CP.MP.50 — Drugs of Abuse: Definitive Drug Testing
MED207.154 — Drug Testing (e.g. Pain Management and Substance Use Disorder Monitoring) and Screening
ANTHEM-CG-LAB-09 — CG-LAB-09 Drug Testing or Screening in the Context of Substance Use Disorder and Chronic Pain
A54799 — Billing and Coding: Urine Drug Testing
A55001 — Billing and Coding: Urine Drug Testing
A56818 — Billing and Coding: Urine Drug Testing